Post by Gilead Sciences

Name: #GileadNews: U.S. FDA approves our treatment for first-line metastatic triple-negative breast cancer
Uploaded: 2026-06-24T20:36:27.339Z
Channel: Gilead Sciences
Description: #GileadNews: U.S. FDA approves our treatment for first-line metastatic triple-negative breast cancer (mTNBC), marking a new backbone therapy for people who previously had few options. Read how this m

832,915 followers

#GileadNews: U.S. FDA approves our treatment for first-line metastatic triple-negative breast cancer (mTNBC), marking a new backbone therapy for people who previously had few options. Read how this marks a momentous step in our mission to expand treatment options for people who historically had few: https://gilead.inc/4eZCm3k

Video Content